Evaluation of the Clinical Benefit of Cancer Drugs Submitted for Reimbursement Recommendation Decisions in Canada
出版年份 2021 全文链接
标题
Evaluation of the Clinical Benefit of Cancer Drugs Submitted for Reimbursement Recommendation Decisions in Canada
作者
关键词
-
出版物
JAMA Internal Medicine
Volume -, Issue -, Pages -
出版商
American Medical Association (AMA)
发表日期
2021-02-23
DOI
10.1001/jamainternmed.2020.8588
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- FDA Approval and Regulation of Pharmaceuticals, 1983-2018
- (2020) Jonathan J. Darrow et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019
- (2020) Emerson Y. Chen et al. JAMA Internal Medicine
- Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
- (2020) Talal Hilal et al. JAMA Internal Medicine
- Association between commercial funding of Canadian patient groups and their views about funding of medicines: An observational study
- (2019) Joel Lexchin PLoS One
- Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study
- (2019) Joel Lexchin BMJ Open
- Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
- (2019) Huseyin Naci et al. BMJ-British Medical Journal
- The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011–2017
- (2018) Chris Skedgel et al. PHARMACOECONOMICS
- Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over Time
- (2018) Ronak Saluja et al. Journal of Oncology Practice
- Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials
- (2018) Ariadna Tibau et al. JAMA Oncology
- A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology
- (2018) Alyson Haslam et al. EUROPEAN JOURNAL OF CANCER
- New Cancer Drug Approvals From the Perspective of a Universal Healthcare System: Analyses of the Pan-Canadian Oncology Drug Review Recommendations
- (2018) Saroj Niraula et al. Journal of the National Comprehensive Cancer Network
- Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology
- (2018) Bruno Kovic et al. JAMA Internal Medicine
- Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
- (2017) Ariadna Tibau et al. JNCI-Journal of the National Cancer Institute
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
- (2017) Ariadna Tibau et al. JNCI-Journal of the National Cancer Institute
- An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical Trials
- (2016) Hemanth Kumar et al. JAMA Oncology
- Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival
- (2015) Chul Kim et al. JAMA Internal Medicine
- Five Years of Cancer Drug Approvals
- (2015) Sham Mailankody et al. JAMA Oncology
- American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
- (2014) Lee M. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity
- (2014) Tito Fojo et al. JAMA Otolaryngology-Head & Neck Surgery
- Progression-Free Survival: Meaningful or Simply Measurable?
- (2012) Christopher M. Booth et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search